Current and historical daily PE Ratio for CRL (
Charles River Laboratories International Inc
) from 2000 to May 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Charles River Laboratories International stock (CRL) PE ratio as of May 11 2024 is 26.77.
More Details
Charles River Laboratories International Inc (CRL) PE Ratio (TTM) Chart
Charles River Laboratories International Inc (CRL) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Charles River Laboratories International PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-11 | 26.8 | 2024-03-08 | 28.9 |
| 2024-05-10 | 26.8 | 2024-03-07 | 29.3 |
| 2024-05-09 | 27.0 | 2024-03-06 | 28.5 |
| 2024-05-08 | 27.6 | 2024-03-05 | 28.3 |
| 2024-05-07 | 27.7 | 2024-03-04 | 28.1 |
| 2024-05-06 | 27.6 | 2024-03-01 | 28.6 |
| 2024-05-03 | 27.4 | 2024-02-29 | 27.5 |
| 2024-05-02 | 27.0 | 2024-02-28 | 27.8 |
| 2024-05-01 | 27.3 | 2024-02-27 | 27.4 |
| 2024-04-30 | 26.9 | 2024-02-26 | 27.0 |
| 2024-04-29 | 27.2 | 2024-02-23 | 26.8 |
| 2024-04-26 | 26.9 | 2024-02-22 | 26.8 |
| 2024-04-25 | 26.7 | 2024-02-21 | 26.1 |
| 2024-04-24 | 28.1 | 2024-02-20 | 25.9 |
| 2024-04-23 | 28.2 | 2024-02-16 | 26.5 |
| 2024-04-22 | 27.3 | 2024-02-15 | 26.6 |
| 2024-04-19 | 26.6 | 2024-02-14 | 26.6 |
| 2024-04-18 | 26.7 | 2024-02-13 | 23.9 |
| 2024-04-17 | 27.0 | 2024-02-12 | 24.5 |
| 2024-04-16 | 27.3 | 2024-02-09 | 24.1 |
| 2024-04-15 | 27.7 | 2024-02-08 | 23.7 |
| 2024-04-12 | 28.3 | 2024-02-07 | 23.7 |
| 2024-04-11 | 28.9 | 2024-02-06 | 23.9 |
| 2024-04-10 | 29.1 | 2024-02-05 | 23.6 |
| 2024-04-09 | 30.2 | 2024-02-02 | 23.6 |
| 2024-04-08 | 29.9 | 2024-02-01 | 23.8 |
| 2024-04-05 | 29.7 | 2024-01-31 | 23.4 |
| 2024-04-04 | 29.4 | 2024-01-30 | 24.3 |
| 2024-04-03 | 30.4 | 2024-01-29 | 24.3 |
| 2024-04-02 | 30.7 | 2024-01-26 | 23.9 |
| 2024-04-01 | 31.5 | 2024-01-25 | 23.1 |
| 2024-03-28 | 31.8 | 2024-01-24 | 23.1 |
| 2024-03-27 | 29.2 | 2024-01-23 | 23.2 |
| 2024-03-26 | 28.8 | 2024-01-22 | 23.4 |
| 2024-03-25 | 28.8 | 2024-01-19 | 23.0 |
| 2024-03-22 | 29.5 | 2024-01-18 | 22.3 |
| 2024-03-21 | 29.6 | 2024-01-17 | 22.1 |
| 2024-03-20 | 29.1 | 2024-01-16 | 22.4 |
| 2024-03-19 | 28.9 | 2024-01-12 | 22.9 |
| 2024-03-18 | 28.4 | 2024-01-11 | 23.1 |
| 2024-03-15 | 28.1 | 2024-01-10 | 23.1 |
| 2024-03-14 | 28.2 | 2024-01-09 | 23.3 |
| 2024-03-13 | 28.3 | 2024-01-08 | 24.6 |
| 2024-03-12 | 28.6 | 2024-01-05 | 24.3 |
| 2024-03-11 | 28.5 | 2024-01-04 | 24.2 |
Charles River Laboratories International Inc (CRL) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Charles River Laboratories International Inc
NAICS : 541714
SIC : 8732
ISIN : US1598641074
Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers